Table 1.
Sample characteristics
| Characteristics | Category | Value [n (%)] |
|---|---|---|
| Sex | Male | 72 (57.1) |
| Female | 54 (42.9) | |
| Age, years | Mean (SD) [Range] | 45.1 (14) [18–78] |
| Young (18–49 years) | 71 (56.3) | |
| Mature (>50 years) | 55 (43.7) | |
| Occupation | No occupation | 92 (73) |
| Occupation | 34 (27) | |
| Education | Elementary school | 10 (7.9) |
| Middle school | 45 (35.7) | |
| High school | 56 (44.4) | |
| University degree | 15 (11.9) | |
| Marital status | Maiden/divorced | 91 (72.2) |
| Married | 35 (27.8) | |
| Parental status | Has children | 51 (40.5) |
| No children | 75 (59.5) | |
| Smoking | Yes | 66 (52.4) |
| No | 60 (47.6) | |
| Diagnosis | Schizophrenia-spectrum disorder | 84 (66.7) |
| Bipolar disorder | 42 (33.3) | |
| History of substance misuse | Yes | 18 (14.3) |
| No | 108 (85.7) | |
| Family history of psychiatric disorders | Yes | 45 (35.7) |
| No | 81 (64.3) | |
| Antipsychotic administration | Oral | 78 (61.9) |
| LAI | 48 (38.1) | |
| Antipsychotic group | LAI muscarinic | 15 (11.9) |
| LAI adrenergic | 6 (4.8) | |
| LAI serotonergic/dopaminergic | 25 (19.8) | |
| Muscarinic | 31 (24.6) | |
| Adrenergic | 25 (19.8) | |
| Serotonergic/dopaminergic | 23 (18.3) | |
| Dopaminergic | 1 (0.8) | |
| Antipsychotic dosagea | Target (LAI) | 46 (36.5) |
| Target (oral) | 61 (48.4) | |
| Low (oral) | 19 (15.1) |
LAI long-acting injectable, SD standard deviation
aAntipsychotics were divided into target and low, according to the dosage range recommended in recent literature [22]